Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Medical Technology, School of Allied Health Sciences, Walailak University, Tha Sala, Nakhon Si Thammarat, Thailand.
PLoS Negl Trop Dis. 2022 Oct 21;16(10):e0010857. doi: 10.1371/journal.pntd.0010857. eCollection 2022 Oct.
Malaria and filariasis are significant vector-borne diseases that are co-endemic in the same human populations. This study aims to collate the evidence, probability, and characteristics of malaria and filariasis co-infections in participants among studies reporting the co-occurrence of both diseases.
We searched for potentially relevant articles reporting the co-occurrence of malaria and filariasis in five electronic databases (Embase, PubMed, Scopus, Medline, and CENTRAL) from inception to May 22, 2022. We estimated the pooled prevalence and probability of malaria and filariasis co-infections among study participants using random-effects meta-analyses and synthesized the characteristics of patients with co-infections narratively.
We identified 951 articles, 24 of which (96,838 participants) met eligibility criteria and were included in the systematic review. Results of the meta-analysis showed a pooled prevalence of malaria and filariasis co-infections among participants of 11%. The prevalence of co-infections was 2.3% in Africa, 0.2% in Asia, and 1.6% in South America. The pooled prevalences of malaria and Wuchereria bancrofti, malaria and Loa loa, malaria and Mansonella perstans co-infections were 0.7%, 1.2%, and 1.0%, respectively. The meta-analysis results showed that the co-infections between two parasites occurred by probability (P = 0.001). Patients with co-infections were at increased risk of having an enlarged spleen, a lower rate of severe anemia, lower parasite density, and more asymptomatic clinical status. Patients with co-infections had decreased levels of C-X-C motif chemokine 5, tumor necrosis factor-α, interleukin-4, c4 complement, and interleukin-10. In addition, patients with co-infections had a lower interleukin-10/tumor necrosis factor-α ratio and higher interleukin-10/interleukin-6 ratio.
The present study showed that the prevalence of malaria and filariasis co-infections was low and varied between geographical areas in the selected articles. Co-infections tended to occur with a low probability. Further studies investigating the outcomes and characteristics of co-infections are needed.
疟疾和丝虫病都是重要的媒介传播疾病,在同一人群中同时流行。本研究旨在整理在报告这两种疾病同时发生的研究中,参与者中疟疾和丝虫病合并感染的证据、概率和特征。
我们从五个电子数据库(Embase、PubMed、Scopus、Medline 和 CENTRAL)中搜索了可能与报告疟疾和丝虫病同时发生的相关文章,检索时间截至 2022 年 5 月 22 日。我们使用随机效应荟萃分析估计了研究参与者中疟疾和丝虫病合并感染的 pooled prevalence 和 probability,并以叙述的方式综合了合并感染者的特征。
我们确定了 951 篇文章,其中 24 篇(96838 名参与者)符合入选标准并纳入系统评价。荟萃分析结果显示,参与者中疟疾和丝虫病合并感染的 pooled prevalence 为 11%。非洲地区合并感染的 prevalence 为 2.3%,亚洲为 0.2%,南美洲为 1.6%。疟疾和班氏丝虫、疟疾和罗阿丝虫、疟疾和曼氏裂头蚴合并感染的 pooled prevalence 分别为 0.7%、1.2%和 1.0%。荟萃分析结果显示,两种寄生虫之间的合并感染是由概率引起的(P=0.001)。合并感染者发生脾肿大、严重贫血发生率较低、寄生虫密度较低、临床无症状状态较多的风险增加。合并感染者的 C-X-C 基序趋化因子 5、肿瘤坏死因子-α、白细胞介素-4、C4 补体和白细胞介素-10 水平降低。此外,合并感染者的白细胞介素-10/肿瘤坏死因子-α 比值降低,白细胞介素-10/白细胞介素-6 比值升高。
本研究表明,在所选择的文章中,疟疾和丝虫病合并感染的 prevalence 较低,且在不同地理区域之间存在差异。合并感染的发生概率较低。需要进一步研究合并感染的结局和特征。